The new guidelines for the introduction of peanut in both the healthy infants and those at high risk for allergy will become an addendum to NIAID’s 2010 Guidelines for the Diagnosis and Management of Food Allergies. Following is a summary of the draft guidance for high-risk children: • The expert panel recommends that, to reduce […]
March 15, 2016 – If you felt a sense of trepidation after reading the results of the new LEAP-On follow-up study, you’re not alone – many people in the food allergy community are going through a bout of culture shock. There’s no denying that the results of 2015’s LEAP and this month’s LEAP-On are quite […]
A pharmaceutical approach to oral immunotherapy is a step closer to approval by the Food and Drug Administration. The treatment, called AR101, is being developed by a company called Aimmune Therapeutics. The company’s aim is to make people less allergic to peanuts by having them take a specially formulated peanut powder in increasing doses over […]
While oral immunotherapy for peanut allergy grabs plenty of headlines, the question is often raised whether the technique will work for tree nuts as well. In a study presented at the AAAAI meeting in March 2016, researchers from the University of Arkansas say they’ve observed that walnut OIT can effectively and safely desensitize patients to […]
Highly positive results seen for early peanut and egg introduction, but more study needed on other allergens.